News
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates Valneva SE research report, reiterating Buy recommendation with a target price of €8.60 based on strong FY/23 product revenue recovery and positive outlook for travel vaccines and future prospects -
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Kaufen
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
-
COMMUNIQUÉ DE PRESSE
Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy